InvestorsHub Logo
Followers 183
Posts 19312
Boards Moderated 0
Alias Born 03/07/2009

Re: Havoc23 post# 41030

Wednesday, 03/29/2017 7:56:42 AM

Wednesday, March 29, 2017 7:56:42 AM

Post# of 106839
Exactly my point. The benefits of RMAT, if assigned, is merely an expedited pre approval process for the actual FDA approval. The drug is in phase 2 for 10 years now with no competitors taking notice. In the mean time, the company almost went broke and lost its patent status. And now it's supposed to have a billon $ market value as some claim?